Evolent Health (EVH) Operating Expenses (2015 - 2026)

Evolent Health has reported Operating Expenses for 12 years, with the latest figure at $506.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 4.45% year-over-year to $506.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (down 4.92% YoY), and the FY2025 full-year result was $2.3 billion, down 11.9% from the prior year.
• Operating Expenses for Q1 2026 stood at $506.8 million, down from $877.0 million in the prior quarter.
• The five-year high for Operating Expenses was $877.0 million in Q4 2025, with the low at $299.9 million in Q1 2022.
• Average Operating Expenses over 5 years is $516.0 million, with a median of $490.7 million recorded in 2023.
• Year-over-year, Operating Expenses jumped 55.74% in 2023 and slumped 30.32% in 2025.
• Tracing EVH's Operating Expenses over 5 years: stood at $384.3 million in 2022, then jumped by 50.24% to $577.4 million in 2023, then advanced by 15.19% to $665.1 million in 2024, then jumped by 31.84% to $877.0 million in 2025, then slumped by 42.2% to $506.8 million in 2026.
• The last three Operating Expenses figures came in at $506.8 million (Q1 2026), $877.0 million (Q4 2025), and $478.6 million (Q3 2025), per Business Quant data.

Peer Comparison